title: [Treatment possibilities in patients with glioblastoma multiforme].
abstract: Glioblastoma multiforme is the most common primary malignant brain tumor in adults. The actual treatment approach includes surgical excision of the lesion followed by radio- and chemotherapy in standard doses and regimens. In most cases, in spite of aggressive treatment, the survival does not exceed 12-16 months after the initial diagnosis. The present survey provides systematic information about the current treatment modalities for control of the disease as well as the perspectives of introduction of some experimental methods in clinical practice.
authors.forename: E
authors.initials: E
authors.lastname: Naydenov
authors.forename: Chr
authors.initials: C
authors.lastname: Tzekov
authors.forename: V
authors.initials: V
authors.lastname: Bussarsky
authors.forename: S
authors.initials: S
authors.lastname: Nachev
authors.forename: V
authors.initials: V
authors.lastname: Tzekova
authors.forename: T
authors.initials: T
authors.lastname: Hadjieva
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects / Q000528:radiation effects / Q000601:surgery*; D001932:Brain Neoplasms / Q000601:surgery* / Q000628:therapy*; D005909:Glioblastoma / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery* / Q000628:therapy*; D006801:Humans
chemical_list: D000970:Antineoplastic Agents